Gyre Therapeutics (GYRE) EPS (Basic) (2010 - 2026)
Gyre Therapeutics (GYRE) reported EPS (Basic) of -$0.1 for Q1 2026, down 433.33% year-over-year from $0.03 in Q1 2025, and down 400.0% on a QoQ basis from -$0.02 in Q4 2025.
Gyre Therapeutics (GYRE) has 17 years of EPS (Basic) data on file, last reported at -$0.1 in Q1 2026.
- Quarterly EPS (Basic) fell 433.33% year-over-year to -$0.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.08 (down 200.0% YoY) and the FY2025 annual result came in at $0.06, down 57.14% from the prior year.
- EPS (Basic) eased to -$0.1 in Q1 2026 per GYRE's latest filing, from -$0.02 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.64 in Q2 2022 and bottomed at -$1.54 in Q4 2023.
- The 5-year median for EPS (Basic) is $0.01 (2024), against an average of -$0.09.
- The widest annual swing landed in 2022, when EPS (Basic) jumped 356.25%; it then plunged 1619.09% in 2025.
- Tracing GYRE's EPS (Basic) over 5 years: stood at -$1.28 in 2022, then dropped by 20.31% to -$1.54 in 2023, then soared by 99.92% to -$0.0 in 2024, then sank by 1619.09% to -$0.02 in 2025, then tumbled by 400.0% to -$0.1 in 2026.
- Per Business Quant, the three latest GYRE EPS (Basic) figures stand at -$0.1 (Q1 2026), -$0.02 (Q4 2025), and $0.04 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 4.06 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 6.99 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.55 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.02 |
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.09 |
| Dec 31, 2023 | -1.54 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | -1.28 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | 1.64 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.80 |
| Jun 30, 2021 | -0.64 |
| Mar 31, 2021 | -0.79 |
| Dec 31, 2020 | -0.88 |
| Sep 30, 2020 | -0.73 |
| Jun 30, 2020 | -0.96 |
| Mar 31, 2020 | -0.28 |
| Dec 31, 2019 | -1.13 |
| Sep 30, 2019 | -1.06 |
| Jun 30, 2019 | -1.15 |
| Mar 31, 2019 | -1.26 |
| Dec 31, 2018 | -0.93 |
| Sep 30, 2018 | -0.64 |
| Jun 30, 2018 | -0.54 |
| Mar 31, 2018 | -0.56 |
| Dec 31, 2017 | -0.96 |
| Sep 30, 2017 | -1.34 |
| Jun 30, 2017 | -2.53 |
| Mar 31, 2017 | -4.57 |
| Dec 31, 2016 | -4.65 |
| Sep 30, 2016 | -6.04 |
| Jun 30, 2016 | -6.33 |
| Mar 31, 2016 | -4.71 |
| Dec 31, 2015 | -0.45 |
| Sep 30, 2015 | -0.93 |
| Jun 30, 2015 | -4.60 |
| Mar 31, 2015 | -7.67 |
| Dec 31, 2014 | -3.51 |
| Sep 30, 2014 | -4.08 |
| Jun 30, 2014 | -5.68 |
| Mar 31, 2014 | -4.75 |
| Dec 31, 2013 | -0.40 |
| Sep 30, 2013 | -0.38 |
| Jun 30, 2013 | -0.37 |
| Mar 31, 2013 | -0.24 |
| Dec 31, 2012 | -0.47 |
| Sep 30, 2012 | -0.24 |
| Jun 30, 2012 | 0.43 |
| Mar 31, 2012 | 0.07 |
| Dec 31, 2011 | -0.29 |
| Sep 30, 2011 | -0.27 |
| Jun 30, 2011 | -0.07 |
| Mar 31, 2011 | 0.43 |
| Dec 31, 2010 | -0.08 |
| Sep 30, 2010 | 0.09 |
| Jun 30, 2010 | 0.13 |